[go: up one dir, main page]

MXPA04011990A - Composiciones farmaceuticas estabilizadas en la base de aceite de ricino polioxietilado y metodo para fabricar el mismo. - Google Patents

Composiciones farmaceuticas estabilizadas en la base de aceite de ricino polioxietilado y metodo para fabricar el mismo.

Info

Publication number
MXPA04011990A
MXPA04011990A MXPA04011990A MXPA04011990A MXPA04011990A MX PA04011990 A MXPA04011990 A MX PA04011990A MX PA04011990 A MXPA04011990 A MX PA04011990A MX PA04011990 A MXPA04011990 A MX PA04011990A MX PA04011990 A MXPA04011990 A MX PA04011990A
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
stabilised
basis
manufacturing
same
Prior art date
Application number
MXPA04011990A
Other languages
English (en)
Inventor
Cirkva Ales
Original Assignee
Pliva Lachema As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Lachema As filed Critical Pliva Lachema As
Publication of MXPA04011990A publication Critical patent/MXPA04011990A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invencion se relaciona a una composicion farmaceutica estabilizada que comprende una sustancia farmaceuticamente activa pobremente soluble en agua, un agente de solubilizacion con un bajo contenido de compuestos acidicos y basicos, y un solvente organico polar, en particular, un concentrado de inyeccion estabilizado, metodos para preparar tales composiciones farmaceuticas estabilizadas y el uso de un agente de solubilizacion con un bajo contenido de compuestos acidicos y basicos para estabilizar composiciones farmaceuticas de sustancias farmaceuticamente activas.
MXPA04011990A 2002-06-10 2003-05-16 Composiciones farmaceuticas estabilizadas en la base de aceite de ricino polioxietilado y metodo para fabricar el mismo. MXPA04011990A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20022027A CZ294371B6 (cs) 2002-06-10 2002-06-10 Stabilizovaná farmaceutická kompozice na bázi polyoxyethylovaného ricinového oleje a způsob její přípravy
PCT/EP2003/005153 WO2003103714A1 (en) 2002-06-10 2003-05-16 Stabilised pharmaceutical compositions on the basis of polyoxyethylated castor oil and method for manufacturing the same

Publications (1)

Publication Number Publication Date
MXPA04011990A true MXPA04011990A (es) 2005-08-16

Family

ID=29721409

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04011990A MXPA04011990A (es) 2002-06-10 2003-05-16 Composiciones farmaceuticas estabilizadas en la base de aceite de ricino polioxietilado y metodo para fabricar el mismo.

Country Status (19)

Country Link
US (1) US20050142225A1 (es)
EP (1) EP1515751A1 (es)
JP (1) JP2005534656A (es)
KR (1) KR20050010030A (es)
CN (1) CN1655824A (es)
AU (1) AU2003240661A1 (es)
BR (1) BR0311687A (es)
CA (1) CA2487889A1 (es)
CZ (1) CZ294371B6 (es)
EA (1) EA007223B1 (es)
HR (1) HRP20041107A2 (es)
IL (2) IL165027A0 (es)
IS (1) IS7551A (es)
MX (1) MXPA04011990A (es)
NZ (1) NZ537150A (es)
PL (1) PL372071A1 (es)
RS (1) RS106704A (es)
WO (1) WO2003103714A1 (es)
ZA (1) ZA200408892B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050232981A1 (en) 2004-04-15 2005-10-20 Ben-Sasson Shmuel A Compositions capable of facilitating penetration across a biological barrier
GT200500310A (es) * 2004-11-19 2006-06-19 Compuestos organicos
CA2597223A1 (en) * 2005-02-10 2006-08-17 Sindan Pharma Srl Method of purifying a surfactant by ultrafiltration
EP1690551A3 (en) 2005-02-10 2006-10-18 Sindan Pharma Srl Method of purifying a surfactant by ultrafiltration
SA06270147B1 (ar) 2005-06-09 2009-12-22 نوفارتيس ايه جي عملية لتخليق 5-(مثيل–1h–إيميدازول–1-يل )–3-(ثلاثي فلـورو مثيل)–بنزامـين
DE102007055341A1 (de) * 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
DE102008011691A1 (de) * 2008-02-28 2009-09-10 Schülke & Mayr GmbH Stabilisierte, antimikrobiell wirksame Zusammensetzung mit einem Gehalt an Bispyridiniumalkan
CN101596159B (zh) * 2008-06-03 2012-12-19 哈药集团生物工程有限公司 一种紫杉醇注射液及其制备方法
HRP20170929T1 (hr) 2008-09-17 2017-09-22 Chiasma Inc. Farmaceutski pripravci i odgovarajući postupci za isporuku
PE20120032A1 (es) * 2008-11-21 2012-02-12 Boehringer Ingelheim Int Composicion farmaceutica oral de un derivado de n-[4-(8-bromo-7-metoxiquinolin-2-il)-1,3-tiazol-2-il]-2-metilpropanamida
MA33491B1 (fr) 2009-07-07 2012-08-01 Boehringer Ingelheim Int Composition pharmaceutique pour un inhibiteur de protease virale de l'hépatite c
CN101829051B (zh) * 2010-05-31 2012-09-12 南昌弘益科技有限公司 1’-乙酰氧基胡椒酚乙酸酯注射液
AU2016215350B2 (en) 2015-02-03 2021-11-25 Amryt Endo, Inc. Method of treating diseases
CN105497905A (zh) * 2015-12-30 2016-04-20 钟术光 一种供注射或口服用的辅料
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods
CN112778513A (zh) * 2020-12-30 2021-05-11 江苏优仿医药科技有限公司 一种聚氧乙烯蓖麻油的精制方法及其应用
CN113281425B (zh) * 2021-04-15 2023-06-06 四川汇宇制药股份有限公司 一种聚氧乙烯(35)蓖麻油中游离脂肪酸的检测方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55108823A (en) * 1979-02-13 1980-08-21 Takemoto Oil & Fat Co Ltd Purification of alkylene oxide addition compound
US5112750A (en) * 1985-06-25 1992-05-12 Asama Chemical Co., Ltd. Immobilized cells and culture method utilizing the same
JPH02157274A (ja) * 1988-12-07 1990-06-18 Sumitomo Heavy Ind Ltd 植物油からビタミンｅを分離濃縮する方法
US6150398A (en) * 1991-05-08 2000-11-21 The United States Of America As Represented By The Department Of Health And Human Services Methods for the treatment of cancer
CA2086874E (en) * 1992-08-03 2000-01-04 Renzo Mauro Canetta Methods for administration of taxol
CA2145190A1 (en) * 1992-09-22 1994-03-31 The Government Of The United States Of America As Represented By The Sec Retary, Department Of Health And Human Services Use of taxol for treating lymphomas and breast cancer
KR100371062B1 (ko) * 1992-11-27 2003-04-21 에프.에이치.포울딩 앤드 컴퍼니 리미티드 안정성이향상된주사가능한택솔조성물및이를제형화하는방법
CA2149150C (en) * 1992-11-27 2000-08-01 David R. Carver Injectable taxol composition with improved stability
CA2092271C (en) * 1993-03-09 2009-10-13 Eddie Reed Use of g-csf for treating taxol side-effects
NZ268326A (en) * 1993-07-19 1997-12-19 Angiogenesis Tech Inc Stent with a coating comprising an anti-angiogenic compound, such as taxol, and a polymeric carrier
TW406020B (en) * 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
ATE201962T1 (de) * 1995-04-28 2001-06-15 Loders Croklaan Bv An polyungesättigten fettsäuren reiche triglyceride
DE19536165A1 (de) * 1995-09-28 1997-04-03 Basf Ag Verfahren zur Reinigung von alkoxylierten Fetten
US5925776A (en) * 1997-12-24 1999-07-20 Schein Pharmacetical, Inc. Polyethoxylated castor oil, process of making the same and formulations thereof
JP2000044840A (ja) * 1998-07-28 2000-02-15 Mitsubishi Heavy Ind Ltd 燃料ガス漏洩検知塗膜
US6388112B1 (en) * 1998-10-20 2002-05-14 Ben Venue Laboratories, Inc. Process for purification of solvents useful in the preparation of pharmaceutical compositions
WO2001021529A1 (en) * 1999-09-22 2001-03-29 Nippon Aerosil Co., Ltd. Surface modified fine silica powder and use thereof
JP2001247847A (ja) * 2000-03-03 2001-09-14 Nisshin Oil Mills Ltd:The 水性ゲル化剤
US7115565B2 (en) * 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability

Also Published As

Publication number Publication date
CZ294371B6 (cs) 2004-12-15
IS7551A (is) 2004-11-25
IL165027A (en) 2009-12-24
HRP20041107A2 (en) 2005-02-28
IL165027A0 (en) 2005-12-18
EA200401625A1 (ru) 2005-06-30
EP1515751A1 (en) 2005-03-23
CN1655824A (zh) 2005-08-17
US20050142225A1 (en) 2005-06-30
EA007223B1 (ru) 2006-08-25
WO2003103714A1 (en) 2003-12-18
BR0311687A (pt) 2008-01-15
NZ537150A (en) 2006-09-29
AU2003240661A1 (en) 2003-12-22
ZA200408892B (en) 2006-01-25
CA2487889A1 (en) 2003-12-18
RS106704A (sr) 2006-12-15
CZ20022027A3 (cs) 2004-01-14
JP2005534656A (ja) 2005-11-17
PL372071A1 (en) 2005-07-11
KR20050010030A (ko) 2005-01-26

Similar Documents

Publication Publication Date Title
MXPA04011990A (es) Composiciones farmaceuticas estabilizadas en la base de aceite de ricino polioxietilado y metodo para fabricar el mismo.
WO2008041245A3 (en) Injectable depot composition and it's process of preparation
WO2005041925A3 (en) Compositions and dosage forms for enhanced absorption
GB0215844D0 (en) Organic compounds
AR048878A1 (es) Composiciones topicas de metadona y metodos para usarlas
MX2008009357A (es) Una composicion solida de taxano liofilizada, un procedimiento para preparar dicha composicion solida, una formulacion farmaceuctica y un conjunto (kit) de dicha formulacion.
WO2002022598A8 (en) Quinolinone derivatives as tyrosine kinase inhibitors
PA8575701A1 (es) Preparaciones acidas de insulina con estabilidad mejorada
WO2006037116A3 (en) Semi-solid delivery vehicle and pharmaceutical compositions
WO2006044334A3 (en) Platelet-derived growth factor compositions and methods of use thereof
WO2005065646A3 (en) Novel drug compositions and dosage forms
WO2009029958A3 (en) Implantable delivery device
MY143795A (en) Tetrahydropyridoindole derivatives
WO2005009356A3 (en) Method for the preparation of controlled release formulations
EA200301275A1 (ru) Капсулы для ингаляции
WO2008143240A1 (ja) 特定の有機酸を含有する経口製剤並びに経口製剤の溶出性及び化学的安定性の改善方法
WO2007133751A3 (en) Base-stabilized polyorthoester formulations
TW200716202A (en) Pediatric formulation of topiramate
WO2011076209A3 (en) Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue
WO2002015959A3 (en) Compounds and compositions for delivering active agents
ATE424192T1 (de) Stabile pharmazeutische zubereitungen mit 2-aza- bicyclo 3.3.0 -octan-3-carboxylsäure-derivaten
WO2008087323A8 (fr) Forme galenique pour l'administration par voie trans-muqueuse de paracetamol
WO2007124700A3 (en) Pharmaceutical composition containing taxane derivative destined for the preparation of an infusion solution, method of preparation thereof and use thereof
WO2005007129A3 (en) Topical formulations with bioactive components
TW200616616A (en) Paclitaxel aqueous injection solution and methods for preparing the same

Legal Events

Date Code Title Description
FA Abandonment or withdrawal